Drug Search Results
More Filters [+]

AM-101

Alternative Names: AM-101, AM101, AM 101
Latest Update: 2023-12-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Altamira Therapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AM-101

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Tinnitus|Otitis Media

Phase 2: Otitis Media|Deafness|Tinnitus|Insomnia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2006-7041-83/hah

P2

Not yet recruiting

Insomnia

2019-07-29

TACTT3

P3

Completed

Tinnitus|Otitis Media

2017-12-28

TACTT3

P3

Completed

Tinnitus

2017-12-28

39%

AMPACT1

P3

Completed

Tinnitus|Otitis Media

2017-01-19

Recent News Events